BAYRY News and Press, Bayer AG ADR From 07/13/23

2023-07-13 12:30:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Although mega cap tech...

2023-06-28 10:42:32 ET Catalent ( NYSE: CTLT ) shares extended a four-day decline on Wednesday after confirming that it was the third-party manufacturer linked to the recent FDA rejection of high-dose Eylea developed by Regeneron ( REGN ). The shares of the contract manufa...

2023-06-27 00:48:56 ET Summary Bayer reported mixed Q1 2023 results, matching analyst consensus expectations with regard to profitability and earnings, but missing on topline and guidance. Long term, Bayer remains well-positioned for growth: Bayer's Crop Science Innovation Summit ...

2023-06-10 11:00:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s note: “AI Meets Biotech: Transforming the Drug Development Process ” was previously published in May 2023 . It has since been updated to include the ...

2023-06-08 07:47:37 ET Perrigo Company ( NYSE: PRGO ) has appointed Patrick Lockwood-Taylor as its new President, Chief Executive Officer and member of the Board of Directors, effective June 30, 2023. Lockwood-Taylor j...

2023-06-07 21:51:56 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued. We share the heat map of the most investable candidates that may be worth your time for fur...

2023-05-31 05:55:18 ET Summary Gain Therapeutics is a biotechnology company focused on drug development powered by its SEE-Tx™ target identification platform, which identifies and optimizes binding sites on biological targets that have never before been targeted. The compan...

2023-05-28 01:09:00 ET Summary Two IPOs priced this past week, each raising more than $200 million, while one small issuer delayed, AZTR. Leading the week, Cummins spin-off Atmus Filtration priced at the midpoint to raise $275 million at a $1.6 billion market cap. While the po...

2023-05-23 13:17:29 ET Bayer ( OTCPK:BAYZF ) and Amgen ( AMGN ) were interested in Iveric Bio ( NASDAQ: ISEE ) before it agreed to a $5.9 billion sale to Astellas ( OTCPK:ALPMF ). Iveric ( ISEE ) detailed in a proxy filed on Tuesday that it reached out ...

2023-05-19 05:13:23 ET The European Medicines Agency (EMA) has accepted and validated Swedish Orphan Biovitrum's (Sobi) ( OTCPK:BIOVF ) application seeking approval of hemophilia A therapy efanesoctocog alfa. Sobi and Sanofi ( NASDAQ: SNY ) have a collabo...